Buzz
In medical research, breakthroughs in combating chronic or life-threatening illnesses don’t happen every day. However, given how rapidly science is evolving, such advancements are now occurring much more quickly than they did in past decades or even years.
From aesthetic improvements to life-saving solutions, you'll be amazed at how progress is being made toward overcoming some of the most challenging conditions.
10. Hair Loss
Stem cell research has made regenerative medicine an increasingly promising field in recent years. At RIKEN, Japan’s leading research institute, techniques have been developed to regenerate teeth and specific glands in lab mice by harnessing stem cells' unique ability to transform into almost any kind of cell. But there’s more: This method also shows potential in restoring hair follicles and could one day offer a breakthrough solution to hair loss.
Unlike conventional follicle transplants, which relocate active follicles to areas with hair loss, stem cell-based therapy actually regenerates new follicles. This doesn’t just halt hair loss—it actively encourages new growth. Kyocera, a leading electronics manufacturer, is at the forefront of creating the equipment necessary for this procedure. In the US alone, over 50 million people struggle with hair loss, with about one-third of them being women.
9. Hepatitis C
Hepatitis C is a long-lasting liver infection that is tough to manage, expensive to treat, and can often be fatal. Around 350,000 people globally lose their lives to the disease each year. Previous treatments only worked for 25–75 percent of patients, depending on the virus strain, and came with a range of harsh side effects.
Hepatitis C, once considered incurable, is no longer a death sentence. In 2014, the pharmaceutical company Gilead gained FDA approval for a 12-week, pill-based treatment regimen that has been proven to eliminate the disease in the vast majority of patients.
Soon after, similar medications were approved by major pharmaceutical companies like Merck and AbbVie. While this is a huge step forward, the treatments can be outrageously expensive—costing over $80,000 for a full course in many instances.
8. Parkinson’s Disease
Tyrosine kinase inhibitors, which have been used in the treatment of leukemia for some time, function by triggering a process called autophagy, where the body’s cells dispose of unnecessary material. In a small clinical trial, researchers from Georgetown University discovered that these drugs might also be beneficial for those suffering from Parkinson’s disease.
Patients were administered a much smaller dose of the drug nilotinib than what’s typically used for leukemia treatment, primarily to gauge its tolerance. To everyone's surprise, all participants showed significant improvements in coordination and motor skills. Further testing of blood and spinal fluid revealed a significant reduction in Parkinson’s-related markers.
When follow-up visits were conducted after the treatment was halted, the positive effects seemed to reverse. Nevertheless, researchers remain optimistic, believing this represents the most promising breakthrough in Parkinson’s treatment in over half a century.
7. Blindness
A Florida-based doctor has developed a controversial stem cell treatment aimed at reversing blindness. The controversy stems from the fact that Dr. Jeffrey Weiss is not affiliated with any academic institutions, nor has his method undergone formal clinical trials. Despite this, his procedure—extracting stem cells from bone marrow and injecting them into patients’ eyes—has successfully restored vision to over 100 blind individuals.
By mid-2016, a similar procedure was undergoing clinical trials at Moorfields Eye Hospital in London. This technique involves using a thin layer of polyester to position the stem cells behind the patient’s retina.
6. Herpes
Herpes is an incredibly common virus with over 100 strains, eight of which typically infect humans. Some variants are almost entirely asymptomatic, allowing individuals to carry the virus without ever knowing it. While there is no cure, a promising new approach has nearly wiped out the virus in the lab by editing its DNA.
Researchers employed the gene-editing tool CRISPR to target double-stranded DNA in three different herpes strains, including Epstein-Barr (which is also linked to certain cancers). CRISPR essentially shattered the viral DNA, significantly reducing the virus’s ability to replicate, especially in the case of Epstein-Barr. While the researchers acknowledge the need for more studies, no other treatment has shown such potential for eradicating the herpes virus.
5. Type 1 Diabetes
The American Diabetes Association reports that diabetes ranks as the seventh leading cause of death in the United States. Type 2 diabetes is an acquired condition where the body either doesn't produce enough insulin or fails to use it properly. On the other hand, type 1 diabetes is genetic, marked by a complete absence of insulin, which makes it far harder to control.
Insulin is produced by beta cells in the pancreas, but in individuals with type 1 diabetes, the immune system attacks these cells. Researchers at Harvard Stem Cell Institute have developed a sophisticated and reliable method for turning stem cells into large quantities of pancreatic beta cells, providing the first ever viable method to produce these essential cells in the lab.
The procedure addresses half of the type 1 diabetes challenge, with the overactive immune response being the other key factor. Various approaches to managing this, including the use of immunosuppressants, are currently under consideration.
4. Alzheimer’s Disease
Alzheimer’s is both incurable and irreversible, progressively stealing a person’s mental faculties and memories. However, scientists from the United States and Australia are working to bring two promising new vaccines—shown to target and eliminate the toxic proteins in the brain linked to the disease—into human clinical trials in the near future. These vaccines not only show potential to prevent dementia but might even reverse its effects when used together.
In the meantime, researchers at the Salk Institute have found that THC, the active compound in marijuana, appears particularly effective at clearing the accumulation of these harmful proteins. In laboratory tests, THC significantly lowered toxic protein levels and removed the related inflammatory response. The team also discovered that endocannabinoids, substances similar to THC that the body naturally produces, trigger these beneficial effects on their own.
3. Aging
For decades, researchers have been investigating ways to slow or halt the aging process. In 2005, a scientist from Stanford University showcased a technique that rejuvenated the healing abilities of an aging rodent by connecting its nervous system to a younger mouse. Other studies have focused on medications and dietary supplements to extend life and enhance the body's natural regenerative abilities.
However, a team from the University of Tsukuba may have recently surpassed all prior research by honing in on mitochondria—the cell's powerhouse. They proposed that mitochondrial DNA doesn't naturally mutate, as previously thought, but rather accumulates proteins over time, leading to defects that drive the aging process.
By utilizing stem cells to revitalize these aged cell lines, the team observed the expected outcome—“old” cells transformed back into “young” ones, almost like magic. When combined with the amino acid glycine—which has been shown to partially reverse age-related mitochondrial damage—this breakthrough has researchers thrilled about the possibility of developing an actual age-reversing pill. We're betting there could be quite a significant market for such a product.
2. Cancer (All Of Them)
Cancer encompasses a wide range of related yet distinct conditions, which makes finding a universal cure nearly impossible according to most medical experts. However, a team at Johannes Gutenberg University hasn’t followed that line of thinking. They claim to have made a groundbreaking leap toward a universal cancer vaccine.
The promising results come from testing in lab animals and early-stage human clinical trials. Though it’s referred to as a vaccine, this treatment would be given to patients already battling cancer. It works by injecting small fragments of RNA from the patient's cancer cells into the immune system, prompting it to launch a deadly attack against any cancer cells of the same type. By adjusting the RNA, various forms of cancer can be targeted.
The therapy has been shown to destroy “aggressively growing” tumors in mice. So far, it’s only been tested in humans for safety, which yielded positive results. No other treatment has demonstrated such potential to fight a wide range of cancers.
1. AIDS
In 2012, a clinical trial was conducted on RV144, a potential HIV vaccine, involving rhesus monkeys. It marked the first trial where an HIV vaccine was able to reduce the rate of transmission.
In July 2016, scientists at Case Western Reserve University successfully replicated these findings with macaques. While a modification to the formula didn’t yield positive results, one aspect of the study proved highly advantageous—an RNA screening of the subjects prior to vaccination.
By using these methods, researchers were able to accurately predict the vaccine response in two-thirds of their subjects, which could lay the foundation for the development of “personalized and predictive vaccinology” aimed at more effectively preventing diseases in the future. They are confident that their HIV vaccine formula is now ready for human clinical trials.
